ANEB: Anebulo Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ANEB: Anebulo Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 43.55
Enterprise Value ($M) 28.55
Book Value ($M) 14.96
Book Value / Share 0.36
Price / Book 2.91
NCAV ($M) 14.52
NCAV / Share 0.35
Price / NCAV 3.00

Profitability (mra)
Return on Invested Capital (ROIC) -0.51
Return on Assets (ROA) -1.02
Return on Equity (ROE) -1.18

Liquidity (mrq)
Quick Ratio 17.52
Current Ratio 17.52

Balance Sheet (mrq) ($M)
Current Assets 15.40
Assets 15.84
Liabilities 0.88
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.31
Net Income -8.20

Cash Flow Statement (mra) ($M)
Cash From Operations -8.09
Cash from Investing 0.00
Cash from Financing -0.06

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-27 13D/A English Aron R. 51.10 0.00
02-14 13G Nantahala Capital Management, LLC 8.63

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-09-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 58 7,024 0.83
2025-03-06 34 5,287 0.64
2025-03-05 1,690 10,418 16.22
2025-03-04 5,203 12,834 40.54

(click for more detail)

Similar Companies
ALTS – JanOne Inc. ALVR – AlloVir, Inc.
ALZN – Alzamend Neuro, Inc. ANIX – Anixa Biosciences, Inc.
APM – Aptorum Group Limited


Financial data and stock pages provided by
Fintel.io